INTERNATIONAL PATENT: BIOSSIL INC. FILES APPLICATION FOR "USE OF GARDOS CHANNEL INHIBITORS IN THE TREATMENT OF SICKLE CELL DISEASE"

GENEVA, Feb. 17 -- BIOSSIL INC. (435 Richmond Street West, Unit 1013Toronto, Ontario M5V 0N9) filed a patent application (PCT/IB2024/057522) for "USE OF GARDOS CHANNEL INHIBITORS IN THE TREATMENT OF SICKLE CELL DISEASE" on Aug 02, 2024. With publication no. WO/2025/032465, the details related to the patent application was published on Feb 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MOSA, Alexander Ibrahim (c/o Biossil Inc.435 Richmond Street West, Unit 1013Toronto, Ontario M5V 0N9), MOUCHANTAF, Anthony (c/o Biossil Inc.435 Richmond Street West, Unit 1013Toronto, Ontario M5V 0N9)

Abs...